UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050162
Receipt number R000057112
Scientific Title Risk factors for serious complications associated with the treatment of immune-mediated diseases using a Japanese large-scale database: A large multi-center exploratory study
Date of disclosure of the study information 2023/01/30
Last modified on 2023/02/06 12:16:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Risk factors for serious complications associated with the treatment of immune-mediated diseases using a Japanese large-scale database: A large multi-center exploratory study

Acronym

Risk factors for serious complications associated with the treatment of immune-mediated diseases using a Japanese large-scale database: A large multi-center exploratory study

Scientific Title

Risk factors for serious complications associated with the treatment of immune-mediated diseases using a Japanese large-scale database: A large multi-center exploratory study

Scientific Title:Acronym

Risk factors for serious complications associated with the treatment of immune-mediated diseases using a Japanese large-scale database: A large multi-center exploratory study

Region

Japan


Condition

Condition

Immune-mediated diseases

Classification by specialty

Gastroenterology Clinical immunology Adult
Child

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We evaluated the occurrence of adverse events such as malignant disease, major adverse cardiovascular events (MACE), serious infections, and venous and pulmonary thrombosis in patients with immune-mediated diseases using the Diagnosis Procedure Combination (DPC) database of the medical fee system collected from national university hospitals in Japan.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Prevalence of malignant disease per 100,000 persons; incidence of malignant disease per 100,000 persons; prevalence of MACE per 100,000 persons; incidence of MACE per 100,000 persons; prevalence of serious infections per 100,000 persons; incidence of serious infections per 100,000 persons; prevalence of venous and pulmonary thrombosis per 100,000 persons; incidence of venous and pulmonary thrombosis per 100,000 persons

Key secondary outcomes

Hazard ratio for malignant disease; hazard ratio for MACE, hazard ratio for severe infection; hazard ratio for venous and pulmonary thrombosis


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

We extracted the database records of patients in the database who were diagnosed with immune-mediated diseases between January 2012 and September 2022.

Key exclusion criteria

Patients were excluded from the study if they were diagnosed with malignant disease, MACE, serious infection, or venous or pulmonary thrombosis between April 1, 2008 and December 31, 2011.

Target sample size

200000


Research contact person

Name of lead principal investigator

1st name Masanori
Middle name
Last name Ochi

Organization

Institute of Medicine, University of Tsukuba, Hitachi Medical Education and Research Center

Division name

Department of Gastroenterology

Zip code

317-0077

Address

2-1-1 Jonan, Hitachi, Ibaraki Japan

TEL

+81-294-23-1111

Email

masaochiphi@md.tsukuba.ac.jp


Public contact

Name of contact person

1st name Masnori
Middle name
Last name Ochi

Organization

Faculty of Medicine, University of Tsukuba, Hitachi Medical Education and Research Center

Division name

Department of Gastroenterology

Zip code

317-0077

Address

2-1-1 Jonan, Hitachi, Ibaraki Japan

TEL

+81-294-23-1111

Homepage URL


Email

masaochiphi@md.tsukuba.ac.jp


Sponsor or person

Institute

University of Tsukuba

Institute

Department

Personal name



Funding Source

Organization

University of Tsukuba

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Tsukuba Hospital

Address

2-1-1 Amakubo, Tsukuba, Ibaraki 305-8576 Japan

Tel

029-853-3900

Email

masaochiphi@md.tsukuba.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 09 Month 26 Day

Date of IRB

2022 Year 09 Month 26 Day

Anticipated trial start date

2022 Year 09 Month 26 Day

Last follow-up date

2024 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Centralized Ethics Review Committee: The Database Center, National University Hospitals, The University of Tokyo Hospital


Management information

Registered date

2023 Year 01 Month 27 Day

Last modified on

2023 Year 02 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057112


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name